首页|山东省通过仿制药质量和疗效一致性评价药品备案变更审评关注要点与常见问题

山东省通过仿制药质量和疗效一致性评价药品备案变更审评关注要点与常见问题

扫码查看
目的 对山东省通过仿制药质量和疗效一致性评价药品的备案申报情况进行分析,以提高药品上市许可持有人上市后变更研究的申报质量和效率.方法 对2023年山东省通过仿制药质量和疗效一致性评价药品的上市后变更备案事项和备案内容进行汇总分析,结合技术审评关注点对备案资料中的常见问题进行分析.结果与结论 上市许可持有人应严格落实持有人主体责任,对通过仿制药质量和疗效一致性评价药品的上市后变更开展充分全面的研究验证,确保变更不会对仿制药质量和疗效的一致性带来不良影响.
Key Points and Common Problems in Review of Post-approval Filing Changes of Drugs Passed Quality and Efficacy Consistency Evaluation of Generic Drugs in Shandong Province
Objective To analyze the filing status of drugs that have passed Quality and Efficacy Consistency Evaluation of Generic Drugs in Shandong Province,so as to improve the filing quality and efficiency of change research conducted by marketing authorization holders.Methods The filing categories and contents of post-approval changes of drugs that have passed Quality and Efficacy Consistency Evaluation of Generic Drugs in Shandong Province in 2023 are summarized,and the common problems in the filing documents are analyzed and discussed based on the concern points of the technical review.Results and Conclusion Marketing authorization holders should strictly fulfill the holder's principal responsibility and carry out sufficient and comprehensive research and validation on post-approval changes of the drugs that have passed Quality and Efficacy Evaluation of Generic Drugs to ensure that the changes do not adversely affect the consistency of the quality and efficacy of the generic drugs.

generic drugquality and efficacy consistencyfiling documenttechnical reviewcommon problem

肖连立、张平、马素燕、侯瑾、李德宝、房娟娟

展开 >

山东省食品药品审评查验中心,山东 济南 250014

仿制药 质量和疗效一致性 备案资料 技术审评 常见问题

2024

食品与药品
山东省生物药物研究院

食品与药品

CSTPCD
影响因子:0.537
ISSN:1672-979X
年,卷(期):2024.26(4)
  • 7